Adams Street Partners operates as a global private market investment management firm.
Business Model:
Revenue: $10M
Employees: 201-500
Address: 1 N Wacker Dr
City: Chicago
State: IL
Zip: 60606
Country: US
Adams Street Partners is a global private market investment management firm that offers comprehensive solutions for its investors. As one of the independent, employee-owned firms, Adams Street has established a reputation for strong performance, an extensive knowledge base, and a disciplined investment approach that values quality over quantity. For more than 45 years, Adams Street has gained the experience to successfully manage through some of the most challenging investment cycles. The collective knowledge of the Adams Street team works collaboratively to leverage the global resources of the Firm in navigating the complexities of private markets. Its mission as a premier private markets investment manager is to provide world-class investment performance and maintain the confidence of our investors through our deep understanding of the global private marketplace and deliver exemplary client service.
Contact Phone:
+13125537890
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2011 | Jaspersoft | Unattributed | 11M |
1/2007 | DolEx Dollar Express | Venture Round | - |
2/2006 | Aesthera Corporation | Series C | 11M |
6/2009 | Integral Development Corp | Venture Round | 11M |
11/2006 | MX Logic | Series F | 4M |
7/2019 | TurnKey Vacation Rentals | Series E | 48M |
6/2007 | WiQuest Communications | Series C | 28M |
4/2011 | Spiceworks, Inc. | Series D | 25M |
1/2007 | Actelis Networks | Series E | 22M |
2/2014 | Spiceworks, Inc. | Series E | 57M |
10/2013 | Mintigo | Series C | 10M |
9/2008 | Sportgenic | Series B | 10M |
3/2021 | Advise Health | Series A | 100M |
4/2007 | Cybera | Series C | 18M |
9/2019 | VillageMD | Series B | 100M |
11/2011 | BrightRoll | Series D | 20.3M |
9/2012 | Damballa | Series E | 15M |
6/2014 | Couchbase | Series E | 60M |
3/2016 | Couchbase | Series F | 30M |
7/2022 | ClassDojo | Series D | 125M |
5/2017 | Mintigo | Series E | 0 |
1/2007 | Ancestry | Funding Round | - |
5/2020 | Palvella Therapeutics | Series C | 0 |
12/2006 | Setanta | Private Equity Round | 0 |
5/2016 | Aptinyx | Series A | 0 |
3/2004 | Jazz Pharmaceuticals | Series B | 0 |
9/2010 | Solaria | Series D | 65M |
8/2013 | CareCloud | Series B | 9M |
5/2021 | SymphonyRM | Series B | 0 |
7/2014 | LogRhythm | Series E | 40M |
4/2021 | ThreatQuotient | Venture Round | 0 |
11/2016 | CareCloud | Post-IPO Equity | 0 |
8/2007 | Luminary Micro | Series C | 25M |
6/2001 | Quallaby Corporation | Venture Round | 14.5M |
1/2004 | Borderfree | Series C | 13.8M |
1/1999 | Syneos Health | Venture Round | - |
4/2023 | Altruist | Series D | 0 |
12/2022 | BillionToOne | Series C | 0 |
8/2021 | Reify Health | Series C | 220M |
5/2020 | Couchbase | Series G | 0 |
6/2004 | Proteus Digital Health | Series B | 6.3M |
10/2010 | TriReme Medical | Series D | 17M |
1/2002 | Synchronoss Technologies | Series A | 0 |
5/2001 | Synchronoss Technologies | Series A | 0 |
6/2022 | FalconX | Series D | 0 |
12/2008 | Jaspersoft | Venture Round | 12.5M |
1/2007 | TicketsNow | Series A | 34M |
4/2014 | Telesign | Series B | 40M |
7/2020 | Robinhood | Series F | 0 |
11/2017 | Outpost Medicine, LLC | Series A | 20M |
10/2018 | Qpex Biopharma | Series A | 33M |
5/2001 | Netcontinuum | Series B | 26M |
8/2003 | comScore | Series E | 12M |
1/2011 | PneumRx | Venture Round | 0 |
12/2015 | CBANC | Series B | 4M |
4/2021 | Mineralys Therapeutics | Series A | 0 |
1/2012 | Neuraltus Pharmaceuticals | Series B | 9.6M |
12/2016 | Tripping.com | Series C | 0 |
1/2019 | Millennium Trust Co | Venture Round | - |
5/2013 | Atlantis Computing | Series D | 0 |
3/2011 | RadiumOne | Series B | 31.5M |
6/2015 | RadiumOne | Series C | 54M |
12/2005 | GlobeImmune | Series B | 34.3M |
12/2012 | Naurex | Series B | 0 |
8/2013 | Couchbase | Series D | 25M |
10/2006 | Enfora | Venture Round | 19M |
11/2009 | Zynga | Venture Round | - |
5/2010 | Arroweye Solutions | Private Equity Round | 8.4M |
5/2017 | Smule | Series H | 54M |
8/2003 | Engim | Series B | 18.5M |
5/2019 | Solera Health | Series C | 0 |
4/2019 | Fusion Pharmaceuticals | Series B | 0 |
6/2016 | Smule | Series G | 0 |
10/2018 | Arctic Wolf | Series C | 45M |
12/2017 | Aptinyx | Series B | 70M |
3/2016 | Maxwell Health | Series C | 0 |
12/2014 | Maxwell Health | Series B | 26.4M |
3/2007 | PneumRx | Series B | 0 |
5/2003 | SPS Commerce | Venture Round | 18M |
9/2009 | RadiumOne | Series A | 2M |
8/2014 | Scytl | Series C | 44M |
10/2021 | Orca Security | Series C | 0 |
5/2007 | Convio | Series E | 10.2M |
11/2008 | MX Logic | Series G | 5.7M |
5/2020 | Aircall | Series C | 0 |
2/2021 | Redox | Series D | 45M |
1/2006 | MX Logic | Series E | 6.5M |
12/2007 | MX Logic | Series G | 2.7M |
7/2004 | Convio | Series D | 15M |
6/2021 | Aircall | Series D | 0 |
11/2011 | Rempex Pharmaceuticals | Series B | 67.5M |
9/2014 | BoomTown | Series A | 20.1M |
11/2008 | Arroweye Solutions | Private Equity Round | 23.5M |
9/2015 | Corvus Pharmaceuticals | Series B | 75M |
2/2008 | Snagajob | Series B | 5M |
4/2008 | Visible World | Series C | 25M |
1/2011 | Five9 | Series C | 8.6M |
4/2012 | Five9 | Venture Round | 12M |
3/2014 | ThreatMetrix | Series E | 20M |
11/2016 | TrendKite | Series D | 16.3M |
6/2015 | Chrome River Technologies | Series D | 100M |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
2/2010 | BrightRoll | Series C | 10M |
7/2002 | Sensys Medical | Series D | 0 |
2/2019 | PerimeterX | Series C | 43M |
11/2011 | Pivot Medical | Series C | 32M |
5/2007 | Arroweye Solutions | Series C | 14M |
12/2014 | Naurex | Series C | 0 |
10/2007 | TriReme Medical | Series C | 15.5M |
5/2020 | Homeward | Series A | 20M |
8/2015 | Apto | Series B | 8M |
5/2021 | Homeward | Series B | 136M |
2/2005 | Aesthera Corporation | Series B | 6.5M |
3/2018 | TurnKey Vacation Rentals | Series D | 31M |
3/2017 | TurnKey Vacation Rentals | Series C | 21M |
6/2014 | Visier | Series C | 25.5M |
4/2017 | Cirius Therapeutics | Series A | 0 |
7/2006 | Snagajob | Series A | 9M |
6/2017 | MyHealthTeams | Series A | 7.3M |
9/2019 | PerimeterX | Series C | 0 |
12/2017 | Atox Bio | Series F | 0 |
7/2011 | Adesto Technologies | Series C | 17.4M |
2/2018 | Cofense | Venture Round | - |
6/2022 | Mineralys Therapeutics | Series B | 0 |
5/2004 | PathScale | Series C | 15M |
6/2012 | LogRhythm | Series D | 15M |
3/2003 | Livevault | Series B | 10M |
3/2011 | LogRhythm | Series C | 10M |
9/2004 | MX Logic | Series D | 8M |
12/2019 | Epirium Bio | Series A | 0 |
9/2021 | Nomad Health | Series D | 0 |
2/2019 | GoCardless | Series E | 75M |
1/2007 | FarmLink | Venture Round | 0 |
5/2012 | Cybera | Venture Round | 4.4M |
1/2012 | Donuts | Series A | 0 |
9/2009 | Actelis Networks | Venture Round | 0 |
8/2018 | Cirius Therapeutics | Series A | 9M |
2/2017 | Scytl | Series D | 13M |
3/2016 | Outpost Medicine | Series A | 41M |
11/2019 | Punchh | Series C | 40M |
7/2017 | Lever | Series C | 40M |
2/2002 | Livevault | Venture Round | 8M |
2/2014 | MyHealthTeams | Series A | 3.4M |
8/2021 | Hopin | Series D | 0 |
8/2001 | comScore | Series C | 15M |
11/2022 | DispatchHealth | Series E | 330M |
9/2003 | Quallaby Corporation | Series E | 5M |
2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
8/2012 | MyHealthTeams | Seed Round | 1.8M |
4/2014 | Boundary | Series C | 22M |
3/2017 | Visier | Series D | 0 |
2/2006 | Cybera | Venture Round | 12.8M |
11/2016 | CareCloud Corporation | Series C | 31.5M |
11/2015 | Earnest | Series B | 75M |
2/2021 | PerimeterX | Series D | 0 |
3/2013 | Q2ebanking | Series C | 20M |
2/2018 | Dynamic Signal | Series E | 0 |
4/2021 | ThreatQuotient | Debt Financing | 0 |
1/2016 | healthfinch | Series A | 7.5M |
4/2022 | Reify Health | Series D | 220M |
1/2022 | Dremio | Series E | 0 |
10/2005 | Light Sciences Oncology | Series A | 35M |
1/2004 | E4 X Inc | Series C | 0 |
9/2017 | Fusion Pharmaceuticals | Series A | 0 |
7/2004 | Danger | Series D | 37M |
7/2012 | Borderfree | Series E | 0 |
5/2011 | Naurex | Series A | 18M |
6/2010 | Adesto Technologies | Venture Round | 3.5M |
6/2022 | Nomad Health | Venture Round | 0 |
12/2010 | RetailMeNot | Series B | 90M |
11/2017 | ThreatQuotient | Series C | 30M |
8/2010 | YouSendIt | Series D | 15M |
11/2013 | Hightail | Series E | 0 |
1/2018 | MATRIXX Software | Series C | 0 |
4/2021 | Icosavax | Series B | 0 |
3/2022 | BillionToOne | Series C | 0 |
4/2014 | Damballa | Series E | 13M |
9/2012 | Criteo | Series D | 40M |
3/2011 | Snagajob | Series C | 27M |
8/2019 | MyHealthTeams | Series B | 0 |
11/2015 | MyHealthTeams | Series A | 5M |
8/2018 | Millendo Therapeutics | Venture Round | 30M |
1/2016 | Millendo Therapeutics | Series B | 0 |
8/2001 | Myogen | Series D | 52.4M |
4/2015 | Smule | Series F | 26M |
6/2002 | comScore | Series D | 20M |
6/2021 | Visier | Series E | 125M |
4/2022 | Remote | Series C | 0 |
11/2007 | RadPharm | Series B | 10M |
4/2010 | Amonix | Series B | 0 |
6/2021 | Iterable | Series E | 0 |
3/2009 | Neuraltus Pharmaceuticals | Series A | 17M |
1/2015 | Yeahka | Venture Round | - |
6/2010 | Incline Therapeutics | Series A | 43M |
11/2016 | Sauce Labs | Venture Round | 70M |
2/2010 | WebVisible | Series C | 20M |
8/2005 | Mpex Pharmaceuticals | Series B | 0 |
7/2017 | Solera Health | Series B | 18.3M |
11/2012 | ServiceMax | Series D | 27M |
1/2004 | Aesthera Corporation | Series A | 2.5M |
7/2007 | Stratavia | Series B | 6.3M |
8/2005 | Stratavia | Series A | 3.3M |
11/2014 | Bluprint | Series D | 50M |
10/2011 | MATRIXX Software | Series B | 12M |
9/2015 | Cybera | Private Equity Round | - |
1/2002 | CBeyond | Venture Round | - |
8/2016 | LogRhythm | Venture Round | 50M |
8/2013 | CareCloud Corporation | Series B | 9M |
10/2019 | Icosavax | Series A | 0 |
5/2017 | Snow Software | Venture Round | - |
1/2017 | Included Health (previously Grand Rounds Health and Doctor On Demand) | Venture Round | - |
4/2012 | Neuraltus Pharmaceuticals | Venture Round | 0 |
6/2001 | SPS Commerce | Series D | 10M |
1/2010 | magicJack | Venture Round | - |
5/2009 | Peerless Network | Venture Round | 10.1M |
5/2007 | ShermansTravel Media, LLC | Private Equity Round | 14M |
1/2016 | Skybox Security | Venture Round | - |
3/2006 | RadPharm | Series A | 8M |
5/2009 | Revascular Therapeutics | Series B | 3M |
3/2007 | WhiteFence | Series B | 0 |
1/2018 | Therapy Brands | Venture Round | - |
8/2015 | Orbus Therapeutics | Series A | 32.5M |
5/2008 | Paylocity | Venture Round | 10M |
12/2013 | Bluprint | Series C | 35M |
2/2018 | Partner Therapeutics | Series A | 60M |
5/2013 | Five9 | Series D | 22M |
12/2005 | Light Sciences Oncology | Series A | 32M |
5/2019 | SymphonyRM | Series A | 10M |
7/2022 | ClassDojo | Series D | 0 |
6/2022 | Nomad Health | Venture Round | 0 |
6/2022 | FalconX | Series D | 0 |
6/2022 | Mineralys Therapeutics | Series B | 0 |
4/2022 | Reify Health | Series D | 0 |
4/2022 | Remote | Series C | 0 |
3/2022 | BillionToOne | Series C | 0 |
1/2022 | Dremio | Series E | 0 |
10/2021 | Orca Security | Series C | 0 |
9/2021 | Nomad Health | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|